Drug
Clevudine clinical trials
Also written Levovir.
- studies test it
- 26
- open now
- 0
- in phase 3
- 8
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
26 studies that test it; most in 2007 (6)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2012 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 6
- Phase 3
- 8
- Phase 4
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 1
Bukwang Pharmaceutical (21) · Pharmasset (2) · Eisai Co., Ltd. (1) · Inje University (1) · Triangle Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses clevudine is read from its arms, and is right about nine times in ten.
Testing it · 26
- The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19CompletedPhase 2Bukwang PharmaceuticalNCT04891302Written as Clevudine
- The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19CompletedPhase 2Bukwang PharmaceuticalNCT04347915Written as Clevudine
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBVTerminatedPhase 3Bukwang PharmaceuticalNCT00313274Written as Clevudine
- Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201TerminatedPhase 2Bukwang PharmaceuticalNCT00362700Written as Clevudine
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBVTerminatedPhase 3Bukwang PharmaceuticalNCT00313287Written as clevudine
- Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 TrialsTerminatedPhase 3Bukwang PharmaceuticalNCT00362505Written as Clevudine
- A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodTerminatedPhase 4Bukwang PharmaceuticalNCT01264094Written as Clevudine
- A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)CompletedPhase 4Bukwang PharmaceuticalNCT01264367Written as Clevudine
- A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-BCompletedPhase 3Bukwang PharmaceuticalNCT00672867Written as Clevudine
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedPhase 4Bukwang PharmaceuticalNCT01263002Written as clevudine, Adefovir
- An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BCompletedPhase 4Bukwang PharmaceuticalNCT01264354Written as Clevudine 30mg
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedPhase 4Bukwang PharmaceuticalNCT01264133Written as Clevudine, Adefovir
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedPhase 4Bukwang PharmaceuticalNCT01266005Written as Clevudine
- An Study of Efficacy and Safety of ClevudineCompletedPhase 3Eisai Co., Ltd.NCT01192854Written as Clevudine
- Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo GroupTerminatedPhase 2Bukwang PharmaceuticalNCT00313261Written as Clevudine
- A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male SubjectsCompletedPhase 1Bukwang PharmaceuticalNCT01581242Written as Clevudine, Adefovir dipivoxil , Clevudine+Adefovir dipivoxil
- Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB InfectionCompletedPhase 3Bukwang PharmaceuticalNCT00362635Written as Clevudine
- Long-term Study With ClevudineCompletedPhase 4Bukwang PharmaceuticalNCT00558818Written as Clevudine
- Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B PatientsCompletedPhase 4Bukwang PharmaceuticalNCT00558493Written as Clevudine
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedPhase 4Bukwang PharmaceuticalNCT00641082Written as Clevudine
Codes
What other systems call clevudine · ClinicalTrials.gg INT003040
- MeSH (NLM) C034935clevudineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) IN51MVP5F1CLEVUDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q1100864clevudineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C95210ClevudineOne source FDA
- DrugBank DB06683One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C034935 | clevudine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | IN51MVP5F1 | CLEVUDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q1100864 | clevudine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C95210 | Clevudine | One source FDA |
| DrugBank | DB06683 | — | One source Wikidata |
Also registered as 5-methyl-2'-fluoroarauracil (UNII 37F7D05ANB).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.